{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:29:01Z","timestamp":1773296941230,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1589,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1038\/mt.2012.97","type":"journal-article","created":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T05:19:56Z","timestamp":1338527996000},"page":"1105-1107","source":"Crossref","is-referenced-by-count":5,"title":["Advances in Foamy Virus Vector Technology and Disease Correction Could Speed the Path to Clinical Application"],"prefix":"10.1016","volume":"20","author":[{"given":"Els","family":"Verhoeyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2012.97_bib1","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/mt.2012.41","article-title":"Cell membrane\u2013associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells","volume":"20","author":"Nasimuzzaman","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.97_bib2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/mt.2012.61","article-title":"A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors","volume":"20","author":"Ho","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.97_bib3","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/mt.2011.282","article-title":"Foamy virus vector-mediated gene correction of a mouse model of Wiskott\u2013Aldrich syndrome","volume":"20","author":"Uchiyama","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.97_bib4","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-cell gene therapy for the Wiskott-Aldrich syndrome","volume":"363","author":"Boztug","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2012.97_bib5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature03341","article-title":"Ancient co-speciation of simian foamy viruses and primates","volume":"434","author":"Switzer","year":"2005","journal-title":"Nature"},{"key":"10.1038\/mt.2012.97_bib6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human b-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1038\/mt.2012.97_bib7","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2012.97_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm1393","article-title":"Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1","volume":"12","author":"Ott","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/mt.2012.97_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","article-title":"HIV-1 integration in the human genome favors active genes and local hotspots","volume":"110","author":"Schroder","year":"2002","journal-title":"Cell"},{"key":"10.1038\/mt.2012.97_bib10","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1371\/journal.pbio.0020423","article-title":"Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells","volume":"2","author":"Hematti","year":"2004","journal-title":"PLoS Biol"},{"key":"10.1038\/mt.2012.97_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nm1695","article-title":"Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors","volume":"14","author":"Bauer","year":"2008","journal-title":"Nat Med"},{"key":"10.1038\/mt.2012.97_bib12","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1073\/pnas.0510046103","article-title":"Foamy virus vector integration sites in normal human cells","volume":"103","author":"Trobridge","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2012.97_bib13","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1099\/0022-1317-80-8-2003","article-title":"Properties of human foamy virus relevant to its development as a vector for gene therapy","volume":"80","author":"Hill","year":"1999","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.2012.97_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0092-8674(03)00881-X","article-title":"The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV","volume":"115","author":"Manel","year":"2003","journal-title":"Cell"},{"key":"10.1038\/mt.2012.97_bib15","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1128\/JVI.73.4.2613-2621.1999","article-title":"Foamy virus capsids require the cognate envelope protein for particle export","volume":"73","author":"Pietschmann","year":"1999","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.97_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/gt.2008.173","article-title":"Transduction of human neural progenitor cells with foamy virus vectors for differentiation-dependent gene expression","volume":"16","author":"Rothenaigner","year":"2009","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.97_bib17","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/sj.mt.6300244","article-title":"Transduction of human embryonic stem cells by foamy virus vectors","volume":"15","author":"Gharwan","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.97_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/104303403764539305","article-title":"Comparison of three retroviral vector systems for transduction of nonobese diabetic\/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells","volume":"14","author":"Leurs","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.97_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1182\/blood-2006-04-016741","article-title":"Foamy virus\u2013mediated gene transfer to canine repopulating cells","volume":"109","author":"Kiem","year":"2007","journal-title":"Blood"},{"key":"10.1038\/mt.2012.97_bib20","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1182\/blood-2007-07-102947","article-title":"Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc\u2212\/\u2212 stem cells","volume":"112","author":"Si","year":"2008","journal-title":"Blood"},{"key":"10.1038\/mt.2012.97_bib21","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1371\/journal.ppat.0030074","article-title":"Centrosomal latency of incoming foamy viruses in resting cells","volume":"3","author":"Lehmann-Che","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1038\/mt.2012.97_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/gt.2011.98","article-title":"Comparative analysis of FV vectors with human alpha- or beta-globin gene regulatory elements for the correction of beta-thalassemia","volume":"19","author":"Morianos","year":"2012","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.97_bib23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.exphem.2011.03.003","article-title":"Genetic correction of X-linked chronic granulomatous disease with novel foamy virus vectors","volume":"39","author":"Chatziandreou","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1038\/mt.2012.97_bib24","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2009-05-220798","article-title":"Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors","volume":"114","author":"Frecha","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2012.97_bib25","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/mt.2008.128","article-title":"Targeted cell entry of lentiviral vectors","volume":"16","author":"Funke","year":"2008","journal-title":"Mol Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616325333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616325333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T08:42:06Z","timestamp":1594197726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616325333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1525001616325333"],"URL":"https:\/\/doi.org\/10.1038\/mt.2012.97","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}